A detailed history of Concord Wealth Partners transactions in Danaher Corp stock. As of the latest transaction made, Concord Wealth Partners holds 121 shares of DHR stock, worth $29,089. This represents 0.01% of its overall portfolio holdings.

Number of Shares
121
Previous 166 27.11%
Holding current value
$29,089
Previous $38,000 21.05%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$224.58 - $256.19 $10,106 - $11,528
-45 Reduced 27.11%
121 $30,000
Q4 2023

Apr 30, 2024

SELL
$185.1 - $233.13 $5,923 - $7,460
-32 Reduced 16.16%
166 $38,000
Q4 2023

Feb 05, 2024

SELL
$185.1 - $233.13 $5,923 - $7,460
-32 Reduced 16.16%
166 $38,000
Q3 2023

Apr 30, 2024

BUY
$233.08 - $265.59 $7,458 - $8,498
32 Added 19.28%
198 $49,000
Q3 2023

Oct 25, 2023

SELL
$233.08 - $265.59 $243,801 - $277,807
-1,046 Reduced 84.08%
198 $49,000
Q2 2023

Aug 07, 2023

BUY
$224.99 - $256.14 $116,319 - $132,424
517 Added 71.11%
1,244 $298,000
Q1 2023

Apr 26, 2023

BUY
$239.75 - $277.0 $138,815 - $160,383
579 Added 391.22%
727 $183,000
Q4 2022

Jan 27, 2023

BUY
$241.42 - $282.29 $35,730 - $41,778
148 New
148 $39,000
Q2 2022

Aug 04, 2022

SELL
$237.11 - $299.66 $58,803 - $74,315
-248 Reduced 53.33%
217 $55,000
Q1 2022

Apr 20, 2022

BUY
$257.27 - $315.76 $4,888 - $5,999
19 Added 4.26%
465 $136,000
Q4 2021

Jan 21, 2022

BUY
$292.08 - $329.01 $75,940 - $85,542
260 Added 139.78%
446 $147,000
Q3 2021

Nov 09, 2021

SELL
$272.21 - $332.43 $62,336 - $76,126
-229 Reduced 55.18%
186 $57,000
Q2 2021

Jul 29, 2021

SELL
$225.08 - $271.69 $2,025 - $2,445
-9 Reduced 2.12%
415 $111,000
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $1,911 - $2,213
9 Added 2.17%
424 $95,000
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $88,187 - $101,865
415 New
415 $92,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.